EC Number   |
Inhibitors |
Structure |
|---|
    2.6.1.42 | (1,2-benzoxazol-3-yl)acetic acid |
- |
   |
| 2.6.1.42 | (2,1,3-benzothiadiazol-5-yl)methanol |
- |
|
| 2.6.1.42 | 2-((4-chloro-2,6-difluorobenzyl)amino)-7-oxo-5-propyl-4,7-dihydropyrazolo[1,5-a]-pyrimidine-3-carbonitrile |
oral administration of the compound significantly raises the circulating levels of the branched-chain amino acids leucine, isoleucine, and valine. Compound demonstrates a good dose response, with leucine increasing from 473 microM (basal level) to 1.2 mM in 100 mg/kg treated mice |
|
| 2.6.1.42 | 2-(2-((4-(1H-pyrazol-3-yl)phenyl)carbamoyl)phenyl)acetic acid |
- |
|
| 2.6.1.42 | 2-(2-(5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamido)phenyl)acetic Acid |
- |
|
| 2.6.1.42 | 2-(4-(1H-pyrazol-3-yl)phenyl)-3,4-dihydroisoquinolin-1(2H)-one |
- |
|
| 2.6.1.42 | 2-(methanesulfonyl)-N-phenylbenzamide |
- |
|
| 2.6.1.42 | 2-ethoxy-5-methyl-7-oxo-4,7-dihydropyrazolo[1,5-a]-pyrimidine-3-carbonitrile |
- |
|
| 2.6.1.42 | 2-hydroxy-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide |
- |
|
| 2.6.1.42 | 2-Ketoglutarate |
- |
|
